Medical Equipment

Neuromodulation Market Size Forecast To Achieve $12.87 Billion By 2030 With 11.1% CAGR

May 15, 2026May 19, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports feature advanced enhancements such as market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, delivering more actionable and strategically valuable research.

What Market Value Trend Is Expected For The Neuromodulation Market From 2026 To 2030?

The neuromodulation market has seen significant expansion in recent years. It is anticipated to increase from $7.62 billion in 2025 to $8.45 billion in 2026, achieving a compound annual growth rate (CAGR) of 10.9%. Historically, this market’s growth can be linked to the increasing prevalence of chronic pain conditions, a rising incidence of neurological disorders, greater acceptance of minimally invasive therapies, the expansion of specialized pain management centers, and the availability of advanced implantable devices.

The neuromodulation market is projected to experience swift expansion in the coming years. By 2030, its valuation is anticipated to reach $12.88 billion, exhibiting a compound annual growth rate (CAGR) of 11.1%. This projected growth is driven by several factors, including the increasing integration of AI-assisted neuromodulation systems, a surge in demand for neuromodulation treatments administered at home, broader approved uses for psychiatric and neurological conditions, an intensifying focus on tailored patient stimulation methods, and ongoing technological improvements in biomaterials and device miniaturization. Key trends anticipated during this period encompass a greater uptake of implantable neuromodulation devices, increased utilization of non-invasive neuromodulation techniques, the expanding incorporation of intelligent and programmable stimulators, the broadening scope of neuromodulation applications beyond pain management, and a strengthened emphasis on individualized neurotherapy.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=10142&type=smp

Which Drivers Are Advancing The Neuromodulation Market Growth?

Increased healthcare spending is anticipated to fuel the expansion of the neuromodulation market moving forward. Healthcare expenditure encompasses the total financial outlay on health care and related activities, including the delivery of health services, private and public health insurance, health research, and public health initiatives. Elevated expenditures contribute to the creation and adoption of novel therapies and diagnostic methods for neurological conditions. Furthermore, greater financial backing enables more extensive research into new neuromodulation technologies, thereby enhancing their efficacy, safety, and targeting capabilities. For instance, in May 2024, figures from the Office for National Statistics, a UK-based government department, revealed that total healthcare expenditure registered a 5.6% increase in nominal terms in 2023, representing a 0.9% growth compared to 2022. Thus, the upward trend in healthcare expenditure is a significant driver for the growth of the neuromodulation market.

Which Segment-Based Categories Are Covered In The Neuromodulation Market?

The neuromodulation market covered in this report is segmented –

1) By Technology: Internal Neuromodulation, External Neuromodulation (Non-invasive)

2) By Biomaterial: Polymeric Biomaterial, Metallic Biomaterial, Ceramic Biomaterial

3) By Application: Chronic Pain, Urinary And Fecal Incontinence, Migraine, Failed Back Syndrome, Parkinson Disease, Epilepsy, Tremor, Depression, Other Applications

4) By End-User: Hospitals, Clinics, Home Healthcare

Subsegments:

1) By Internal Neuromodulation: Implantable Devices, Intrathecal Drug Delivery Systems

2) By External Neuromodulation (Non-invasive): Transcranial Magnetic Stimulation (TMS), Transcranial Direct Current Stimulation (tDCS), Transcutaneous Electrical Nerve Stimulation (TENS), Peripheral Nerve Stimulation (PNS)

Which Trends Are Shaping The Neuromodulation Market Landscape?

Major companies in the neuromodulation market are prioritizing the development of advanced devices, such as next-generation implantable pulse generators (IPGs), to enhance therapeutic precision, improve patient comfort, and maintain their competitive position. An IPG is a compact, battery-powered device typically implanted under the skin, often in the chest or abdomen, that delivers targeted electrical stimulation to manage neurological disorders. These innovations aim to provide greater personalization, improved battery longevity, and simplified implantation procedures. For instance, in July 2023, Boston Scientific Corporation, a US-based biotechnology and biomedical engineering firm, secured FDA approval for its Vercise Neural Navigator 5 software with STIMVIEW XT technology, intended for use with the fourth-generation Vercise Genus Deep Brain Stimulation (DBS) System. This platform encompasses both rechargeable and non-rechargeable IPGs and supports five MR-Conditional implantable pulse generators (IPGs), thereby offering the widest array of therapy options to customize DBS treatment for individuals with Parkinson’s disease or essential tremor.

Which Key Players Are Active In The Neuromodulation Market?

Major companies operating in the neuromodulation market are Abbott Laboratories, Soterix Medical Inc., Boston Scientific Corporation, Medtronic plc, Synapse Biomedical Inc., Nevro Corp, NeuroPace Inc., LivaNova PLC, NeuroSigma Inc., Neuronetics Inc., Bioness Inc., Aleva Neurotherapeutics S.A., Integer Holdings Corporation, Inspire Medical Systems Inc., Saluda Medical Pty Ltd, Inbrain Neuroelectronics SAS, Pixium Vision SA, Neuromod Devices Limited, Cognito Therapeutics Inc., PathMaker Neurosystems Inc., Dignify Therapeutics Inc., Neuros Medical Inc., Koninklijke Philips N.V., Omron Corporation

Access The Complete Neuromodulation Market Report:

https://www.thebusinessresearchcompany.com/report/neuromodulation-global-market-report

Which Region Commands The Largest Share Of The Neuromodulation Market?

North America was the largest region in the neuromodulation market in 2025. The regions covered in the neuromodulation market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Access a Neuromodulation Market Report for Deeper Competitive Insights

https://www.thebusinessresearchcompany.com/report/neuromodulation-global-market-report

Browse Through More Reports Similar to the Global Neuromodulation Market 2026, By The Business Research Company

Nephrologists Market Report 2020 2030 Covid 19 Implications And Growth 2026

https://www.thebusinessresearchcompany.com/report/nephrologists-market-global-report-2020-2030-covid-19-implications-and-growth

Neurology Devices Market Report 2026

https://www.thebusinessresearchcompany.com/report/neurology-devices-global-market-report

Brain Monitoring Market Report 2026

https://www.thebusinessresearchcompany.com/report/brain-monitoring-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795